101 related articles for article (PubMed ID: 3089681)
21. Immediate postpartum insertion of the norplant contraceptive device.
Molland JR; Morehead DB; Baldwin DM; Castracane VD; Lasley B; Bergquist CA
Fertil Steril; 1996 Jul; 66(1):43-8. PubMed ID: 8752609
[TBL] [Abstract][Full Text] [Related]
22. Subdermal progestin implant contraception.
Darney PD
Curr Opin Obstet Gynecol; 1991 Aug; 3(4):470-6. PubMed ID: 1908716
[TBL] [Abstract][Full Text] [Related]
23. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on serum lipids.
Shaaban MM; Elwan SI; Abdalla SA; Darwish HA
Contraception; 1984 Nov; 30(5):413-9. PubMed ID: 6440737
[TBL] [Abstract][Full Text] [Related]
24. First year clinical experience with six levonorgestrel rods as subdermal contraception.
Faundes A; Brache de Mejias V; Leon P; Robertson D; Alvarez F
Contraception; 1979 Aug; 20(2):167-75. PubMed ID: 487818
[TBL] [Abstract][Full Text] [Related]
25. Pharmacodynamic effects of levonorgestrel (LNG) administered either orally or subdermally to early postpartum lactating mothers on the urinary levels of follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) in their breast-fed male infants.
Shikary ZK; Betrabet SS; Toddywala WS; Patel DM; Datey S; Saxena BN
Contraception; 1986 Oct; 34(4):403-12. PubMed ID: 3096635
[TBL] [Abstract][Full Text] [Related]
26. Norplant contraceptive implants: rods versus capsules.
Pasquale SA; Brandeis V; Cruz RI; Kelly S; Sweeney M
Contraception; 1987 Sep; 36(3):305-16. PubMed ID: 3119287
[TBL] [Abstract][Full Text] [Related]
27. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women.
Nilsson S; Nygren KG; Johansson ED
Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181
[TBL] [Abstract][Full Text] [Related]
28. Ultrasonic visualization of NORPLANT subdermal contraceptive devices.
Thomsen RJ; Pasquale S; Nosher J
Int J Gynaecol Obstet; 1985 Jun; 23(3):223-7. PubMed ID: 2865186
[TBL] [Abstract][Full Text] [Related]
29. Plasma progesterone levels during long-term treatment with levonorgestrel silastic implants.
Croxatto HB; Diaz S; Pavez M; Miranda P; Brandeis A
Acta Endocrinol (Copenh); 1982 Oct; 101(2):307-11. PubMed ID: 6814139
[TBL] [Abstract][Full Text] [Related]
30. Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction.
Hingorani V; Jalnawala SF; Kochhar M; Rai Chaudhury G; Sengupta PC; Datey S; Mehta S; Roy M; Saxena NC; Saxena BN
Contraception; 1986 Mar; 33(3):233-44. PubMed ID: 3087694
[TBL] [Abstract][Full Text] [Related]
31. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions.
Shaaban MM; Elwan SI; el-Sharkawy MM; Farghaly AS
Contraception; 1984 Nov; 30(5):407-12. PubMed ID: 6440736
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels of levonorgestrel in women during longterm use of norplant.
Croxatto HB; Díaz S; Miranda P; Elamsson K; Johansson ED
Contraception; 1981 Feb; 23(2):197-209. PubMed ID: 6786827
[TBL] [Abstract][Full Text] [Related]
33. Effect of subdermal levonorgestrel contraceptive implants on vaginal candidiasis.
Toppozada M; Amer S; el-Ghazzawi E
Adv Contracept; 1986 Jun; 2(2):117-22. PubMed ID: 3096090
[TBL] [Abstract][Full Text] [Related]
34. Hormonal implants: contraception for a new century.
Darney PD
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
[TBL] [Abstract][Full Text] [Related]
35. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
Coukell AJ; Balfour JA
Drugs; 1998 Jun; 55(6):861-87. PubMed ID: 9617600
[TBL] [Abstract][Full Text] [Related]
36. [Norplant--a subdermal contraceptive implant].
Vukelić J; Belopavlović Z
Med Pregl; 1986; 39(9-10):469-71. PubMed ID: 3108639
[No Abstract] [Full Text] [Related]
37. Ovulation detection following removal of levonorgestrel subdermal contraceptive implants.
Ismail AA; Anwar MY; Youssef SM; Toppozada M
Contraception; 1987 Mar; 35(3):207-14. PubMed ID: 3111783
[TBL] [Abstract][Full Text] [Related]
38. Plasma levels of levonorgestrel in women during longterm use of Norplants.
Croxatto HB; Díaz S; Miranda P; Elamsson K; Johansson ED
Contraception; 1980 Dec; 22(6):583-96. PubMed ID: 6971208
[TBL] [Abstract][Full Text] [Related]
39. Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development.
Brache V; Alvarez F; Faundes A; Cochon L; Thevenin F
Fertil Steril; 1996 Jun; 65(6):1110-4. PubMed ID: 8641481
[TBL] [Abstract][Full Text] [Related]
40. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
